Literature DB >> 15048132

Regulation of aminopeptidase A expression in cervical carcinoma: role of tumor-stromal interaction and vascular endothelial growth factor.

Takayasu Suganuma1, Kazuhiko Ino, Kiyosumi Shibata, Seiji Nomura, Hiroaki Kajiyama, Fumitaka Kikkawa, Nobuo Tsuruoka, Shigehiko Mizutani.   

Abstract

We previously demonstrated that aminopeptidase A (APA), a membrane-bound metallopeptidase degrading bioactive peptides such as angiotensin II (Ang II), is expressed in neoplastic lesions of the uterine cervix, and that its expression is upregulated as the lesion progresses from cervical intraepithelial neoplasms (CIN) toward invasive squamous cell carcinomas (SCC). The present study investigated the regulatory mechanisms involved in APA expression and its potential role in cervical carcinoma. Immunohistochemical staining in high-grade CIN and SCC tissues showed that APA was strongly expressed at the edge of lesions adjacent to cervical stromal cells. Fluorescence-activated cell sorting analysis demonstrated that cell surface APA expression was extremely low in three human SCC cell lines, SiHa, TCS and CaSki, under basal conditions. However, both contact and noncontact cocultures with human cervical fibroblasts resulted in the induction of APA expression in these SCC cells. APA expression was also induced in vivo when TCS cells were subcutaneously inoculated into nude mice. Furthermore, APA expression and enzymatic activity were enhanced by addition of the conditioned medium (CM) from fibroblast culture, but not by heat-treated CM. Among the various cytokines tested, vascular endothelial growth factor (VEGF) significantly increased APA activity, and induction of APA by the fibroblast CM was partly inhibited by anti-VEGF neutralizing antibody. Finally, APA cDNA-transfected APA-overexpressing TCS cells significantly reduced the Ang II-induced cell invasion ability as compared with parental or control vector-transfected TCS cells, although there was no significant difference in cellular proliferation among them. These results suggested the importance of tumor-stromal interaction for the regulation of APA expression in the microenvironment of cervical carcinoma and the potential role for this peptidase in regulating tumor invasion through inactivation of Ang II activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048132     DOI: 10.1038/labinvest.3700072

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

1.  Differential exoprotease activities confer tumor-specific serum peptidome patterns.

Authors:  Josep Villanueva; David R Shaffer; John Philip; Carlos A Chaparro; Hediye Erdjument-Bromage; Adam B Olshen; Martin Fleisher; Hans Lilja; Edi Brogi; Jeff Boyd; Marta Sanchez-Carbayo; Eric C Holland; Carlos Cordon-Cardo; Howard I Scher; Paul Tempst
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

2.  The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro.

Authors:  Malin Wickström; Caroline Haglund; Henrik Lindman; Peter Nygren; Rolf Larsson; Joachim Gullbo
Journal:  Invest New Drugs       Date:  2007-10-06       Impact factor: 3.850

3.  Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival.

Authors:  K Ino; K Shibata; H Kajiyama; E Yamamoto; T Nagasaka; A Nawa; S Nomura; F Kikkawa
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

4.  Aminopeptidase A initiates tumorigenesis and enhances tumor cell stemness via TWIST1 upregulation in colorectal cancer.

Authors:  Hui-Yu Chuang; Jeng-Kae Jiang; Muh-Hwa Yang; Hsei-Wei Wang; Ming-Chun Li; Chan-Yen Tsai; Yau-Yun Jhang; Jason C Huang
Journal:  Oncotarget       Date:  2017-03-28

5.  Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.

Authors:  Qingyu Zhang; Shan Yu; Melody Man Ting Lam; Terence Chuen Wai Poon; Litao Sun; Yufei Jiao; Alice Sze Tsai Wong; Leo Tsz On Lee
Journal:  J Exp Clin Cancer Res       Date:  2019-03-07

Review 6.  The Emerging Roles of miR-125b in Cancers.

Authors:  Ying Wang; Guilin Zeng; Yicheng Jiang
Journal:  Cancer Manag Res       Date:  2020-02-12       Impact factor: 3.989

7.  Derivatives of 5-aminolevulinic Acid for photodynamic therapy.

Authors:  Ryan F Donnelly; Paul A McCarron; A David Woolfson
Journal:  Perspect Medicin Chem       Date:  2007-12-11

8.  miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

Authors:  Andrea Feliciano; Josep Castellvi; Ana Artero-Castro; Jose A Leal; Cleofé Romagosa; Javier Hernández-Losa; Vicente Peg; Angels Fabra; Francisco Vidal; Hiroshi Kondoh; Santiago Ramón Y Cajal; Matilde E Lleonart
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

9.  Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury.

Authors:  Jean-Christophe Wyss; Rajesh Kumar; Josip Mikulic; Manfred Schneider; Jean-Luc Mary; Johannes D Aebi; Lucienne Juillerat-Jeanneret; Dela Golshayan
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.